Executive Vice President, Chief Commercialization Officer
Bristol Myers Squibb

Dr. Christopher Boerner is currently the EVP & Chief Commercialization Officer at Bristol-Myers Squibb where he is accountable for the company’s global commercial activities. Prior to this, Chris has held senior roles leading both the ex-US and US commercial organizations at Bristol-Myers Squibb. He joined BMS in February 2015.

Prior to joining BMS, Chris served as the Executive Vice President of Commercial for Seattle Genetics, Inc., where he led all commercial activities for the company. Previously, he was its Senior Vice President of Commercial and its Vice President of Marketing. Before joining Seattle Genetics, Chris was with Dendreon Corporation, where he led the marketing team. From 2002 to 2010, he was with Genentech, a member of the Roche Group, where he served in a variety of commercial roles, including Director of Marketing on Avastin, Director of Avastin franchise strategy and Associate Director of Oncology Market Development. Prior to Genentech, he was with McKinsey & Company, a global strategic management consulting firm, where he served global pharmaceutical and biotechnology clients.

Chris received his Ph.D. and M.A. in Business Administration from the Haas School of Business at the University of California, Berkeley, and holds an A.B. in Economics and History from Washington University in St. Louis.